Naltrexone is a medicine used to help people stop using drugs like heroin. It works by blocking the effects of drugs, making it harder to get high. It's also used to help people reduce their drinking of alcohol.
Every report comes from a Lived member, sent anonymously.
Have you tried Naltrexone for Alcoholism?
Naltrexone is a prescription medicine that helps people recovering from alcohol use disorder or opioid use disorder avoid returning to drinking or opioid use. It comes in two main forms. Daily tablets, sold as generic naltrexone (the former brand ReVia is no longer marketed in the US), are approved for alcohol dependence and for blocking the effects of opioids in people who have already stopped using them. Vivitrol is a monthly injection approved for alcohol dependence in people who can stop drinking before the first shot, and for preventing relapse after opioid detoxification. For alcohol use disorder, naltrexone is one of the recommended first-line medicines, along with acamprosate. For opioid use disorder, it offers an option that is not itself an opioid, unlike methadone and buprenorphine, which treat the disorder by acting on the same receptors opioids use. That suits some people who want or need opioid-free treatment, although it requires being completely off opioids before starting. In every case, naltrexone is meant to be part of a treatment program that includes counseling or other support; it has not been shown to help when used on its own. Naltrexone is also one of the two ingredients in Contrave, a tablet for long-term weight management that combines it with bupropion, an antidepressant. Very small doses, called low-dose naltrexone or LDN, are sometimes prescribed off-label for fibromyalgia, chronic pain or long COVID. Studies so far have not shown a clear benefit over placebo for fibromyalgia, and the evidence for other uses is weak.
Opioids such as heroin, fentanyl and oxycodone produce pain relief and euphoria by attaching to opioid receptors, docking sites on nerve cells in the brain and body. Naltrexone attaches to the same receptors without activating them, occupying the space an opioid would need. While it is in the body, an ordinary amount of an opioid produces little or no effect. A 50 mg tablet blocks opioids for about a day, and a Vivitrol injection for about four weeks. How it helps with alcohol is less fully understood. The body makes its own opioid-like chemicals, often called endorphins, and research suggests this system plays a part in drinking. Naltrexone blocks these signals too. In clinical studies it reduces drinking, and people often describe it as easing craving. Naltrexone is not habit-forming and does not produce a high. It also does not make people sick if they drink, which sets it apart from disulfiram, an older alcohol medicine designed to cause an unpleasant reaction to even small amounts of alcohol.
Before the first dose, a person must be free of all opioids, including prescription pain medicines, tramadol and opioid-containing cough or diarrhea medicines. The usual recommendation is at least 7 to 10 days opioid-free, and up to two weeks after stopping methadone or buprenorphine. If opioids are still in the body, naltrexone displaces them all at once and can set off sudden, severe withdrawal, with heavy vomiting, diarrhea or confusion, that may need hospital care. This applies to people starting naltrexone for alcohol too, so it is important to tell the prescriber honestly about any recent opioid use. The prescriber may use a urine test or a brief naloxone test dose to check before starting. Tablets are usually taken once a day, with or without food. For alcohol use disorder, 50 mg daily is the usual dose. People treated for opioid use disorder typically start with 25 mg to make sure no withdrawal occurs, then move to 50 mg. Some treatment programs give supervised doses every second or third day instead. Because one tablet's blockade lasts only about a day, taking it consistently matters. Vivitrol is a 380 mg injection into the buttock muscle, given by a healthcare provider every four weeks, alternating sides. It does not require taking tablets first. If an injection is missed, the next one should be given as soon as possible. Unlike an implant, it cannot be removed once injected.
With tablets, the most common side effects are nausea, headache, dizziness, nervousness, tiredness and trouble sleeping. Nausea is the one most likely to make people stop. With Vivitrol, nausea after the first injection is usually mild and fades within a few days, and reactions where the shot was given, such as tenderness, a firm lump, swelling, bruising or itching, are common. Dizziness is a reason to hold off on driving until you know how the medicine affects you. A few less common problems need attention. Naltrexone can rarely injure the liver: yellowing of the skin or eyes, dark urine, light-colored stools, pain in the upper right abdomen or unusual tiredness should be reported to the prescriber right away. Depression and suicidal thoughts have been reported in people treated for alcohol or opioid use disorder; a link to the medicine has not been proven, but new or worsening low mood should be reported promptly, and family members can help watch for it. With Vivitrol, an injection-site reaction that keeps growing, becomes very painful, blisters or turns into an open wound needs prompt evaluation, because a small number of these reactions have needed surgery. Vivitrol has also rarely caused an allergic form of pneumonia, so new shortness of breath, cough or wheezing should be reported promptly.
Because naltrexone blocks opioids, it cannot be combined with opioid pain medicines or with methadone or buprenorphine treatment, and opioid-containing cough, cold and antidiarrheal medicines will not work while taking it. This matters if severe pain ever needs emergency treatment: the medical team may need to use other pain relief, or larger opioid doses with close monitoring. Carrying a wallet card or other identification, and telling every doctor, dentist and surgeon about naltrexone, helps avoid dangerous delays. The most serious risk is opioid overdose. People lose their tolerance to opioids while they are not using them, and naltrexone does not change that. After stopping naltrexone, after a missed dose, or as a Vivitrol injection wears off near the end of the month, an amount a person once used regularly can be enough to stop their breathing. Taking large amounts to try to overpower the blockade can also be fatal. Anyone with a history of opioid use should keep naloxone (Narcan nasal spray, available without a prescription), an overdose-reversal medicine, on hand and make sure family or friends know where it is and how to use it. If someone cannot be woken, is breathing very slowly or not at all, or has blue or purple lips, give naloxone if available and call 911, even if they seem to recover, because naloxone wears off. People with significant liver disease need careful assessment, since naltrexone builds up to much higher levels in cirrhosis. Combining it with disulfiram, another medicine that can strain the liver, is generally avoided. Information on use during pregnancy is limited, so anyone pregnant, planning pregnancy or breastfeeding should talk through the balance of risks with the prescriber.
Once a person is opioid-free, naltrexone produces no high and no withdrawal of its own, and many people notice little beyond mild side effects in the first days. For alcohol, the effect is gradual rather than dramatic: people often describe less craving, and in studies, for every 11 people treated with daily tablets, about one more avoided returning to heavy drinking than with a placebo. The original trials ran for 12 weeks; how long to continue is decided with the prescriber based on how recovery is going. For opioid use disorder, monthly Vivitrol reduces opioid use compared with usual care without this medicine, and it removes the need to remember a daily pill. Getting through the opioid-free period needed to start is often the hardest step, and studies comparing it with methadone or buprenorphine suggest it is probably no better and possibly slightly less effective at reducing opioid use, so some people are better served by those options. Follow-up usually covers drinking or drug use, mood, side effects and any signs of liver problems, alongside counseling or support. Because naltrexone is not habit-forming, stopping it does not cause withdrawal. But stopping ends the opioid blockade, within a day or so for tablets or over the weeks after a last injection, and that is when overdose risk is highest for anyone who returns to opioid use.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Naltrexone, what you've noticed, or ask the community a question.